RobertAgrestiDO

PubMed

• Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.
  Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, ...> ;Ann. Oncol.. 2014-02-01
• Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?
  Belardi V, Fiore E, Giustarini E, Muller I, Sabatini S, Rosellini V, Seregni E, Agresti R, Marcocci C, Vitti P, Giani C> ;J. Endocrinol. Invest.. 2013-05-01
• Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.
  Secreto, G., Meneghini, E., Venturelli, E., Cogliati, P., Agresti, R., Ferraris, C., Gion, M., Zancan, M., Fabricio, A. S., Berrino, F., Cavalleri, A., Micheli, A.> ;Int J Biol Markers. 2011 Dec 20
• Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancer.
  Crippa, F., Agresti, R., Bombardieri, E., Seregni, E., Chiti, A., Greco, M., Andreola, S., Buraggi, G., Veronesi, U.> ;Int J Oncol. 1995 Apr
• Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer.
  Bombardieri, E., Crippa, F., Maffioli, L., Chiti, A., Castellani, M., Greco, M., Agresti, R., Bogni, A., Chiesa, C., Desanctis, V., Massaron, S., Pascali, C.> ;Int J Oncol. 1996 Apr
• Angiosarcoma of the breast and vascular endothelial growth factor receptor.
  Gennaro, M., Valeri, B., Casalini, P., Carcangiu, M. L., Gronchi, A., Conti, A. R., Agresti, R., Greco, M.> ;Tumori. 2011 Mar 11
• Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamic...
  Demicheli, R., Ardoino, I., Boracchi, P., Coradini, D., Agresti, R., Ferraris, C., Gennaro, M., Hrushesky, W. J., Biganzoli, E.> ;BMC Cancer. 2010
• Is there a specific magnetic resonance phenotype characteristic of hereditary breast cancer?
  Trecate, G., Manoukian, S., Suman, L., Vergnaghi, D., Marchesini, M., Agresti, R., Ferraris, C., Peissel, B., Scaramuzza, D., Bergonzi, S.> ;Tumori. 2010 Sep 18
• Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up.
  Martelli, G., Miceli, R., Daidone, M. G., Vetrella, G., Cerrotta, A. M., Piromalli, D., Agresti, R.> ;Ann Surg Oncol. 2011 Jan
• Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness.
  Tagliabue, E., Agresti, R., Casalini, P., Mariani, L., Carcangiu, M. L., Balsari, A., Veronesi, U., Ménard, S.> ;Eur J Cancer. 2006 May
• FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.
  Spinola, M., Leoni, V. P., Tanuma, J., Pettinicchio, A., Frattini, M., Signoroni, S., Agresti, R., Giovanazzi, R., Pilotti, S., Bertario, L., Ravagnani, F., Dragani, T...> ;Oncol Rep. 2005 Aug
• Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CH...
  Fierabracci, P., Pinchera, A., Tonacchera, M., Agretti, P., De Marco, G., Albertini, S., Conforti, G., Seregni, E., Agresti, R., Grasso, L., Giani, C.> ;J Endocrinol Invest. 2004 Oct
• FDG-PET for axillary lymph node staging in primary breast cancer.
  Crippa, F., Gerali, A., Alessi, A., Agresti, R., Bombardieri, E.> ;Eur J Nucl Med Mol Imaging. 2004 Jun
• Immunological and pathobiological roles of fibulin-1 in breast cancer.
  Pupa, S. M., Argraves, W. S., Forti, S., Casalini, P., Berno, V., Agresti, R., Aiello, P., Invernizzi, A., Baldassari, P., Twal, W. O., Mortarini, R., Anichini, A., Mé...> ;Oncogene. 2004 Mar 18
• Role of HER2 in wound-induced breast carcinoma proliferation.
  Tagliabue, E., Agresti, R., Carcangiu, M. L., Ghirelli, C., Morelli, D., Campiglio, M., Martel, M., Giovanazzi, R., Greco, M., Balsari, A., Ménard, S.> ;Lancet. 2003 Aug 16
• Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient''s serum.
  Forti, S., Scanlan, M. J., Invernizzi, A., Castiglioni, F., Pupa, S., Agresti, R., Fontanelli, R., Morelli, D., Old, L. J., Pupa, S. M., Ménard, S.> ;Breast Cancer Res Treat. 2002 Jun
• Early relapse of premenopausal patients after surgery for node-positive breast carcinoma.
  Tagliabue, E., Agresti, R., Ghirelli, C., Morelli, D., Ménard, S.> ;Breast Cancer Res Treat. 2002 Mar
• The early relapse of premenopausal patients after surgery for node-positive breast carcinoma.
  Tagliabue, E., Agresti, R., Ghirelli, C., Morelli, D., Ménard, S.> ;Breast Cancer Res Treat. 2001 Nov
• HER2 as a prognostic factor in breast cancer.
  Ménard, S., Fortis, S., Castiglioni, F., Agresti, R., Balsari, A.> ;Oncology. 2001
• HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.
  Ménard, S., Casalini, P., Campiglio, M., Pupa, S., Agresti, R., Tagliabue, E.> ;Ann Oncol. 2001
• Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
  Greco, M., Crippa, F., Agresti, R., Seregni, E., Gerali, A., Giovanazzi, R., Micheli, A., Asero, S., Ferraris, C., Gennaro, M., Bombardieri, E., Cascinelli, N.> ;J Natl Cancer Inst. 2001 Apr 18
• Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori.
  Greco, M., Gennaro, M., Valagussa, P., Agresti, R., Ferraris, C., Ferrari, B., Urban, C., Gianni, L.> ;Ann Oncol. 2000 Sep
• Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo.
  Ardini, E., Agresti, R., Tagliabue, E., Greco, M., Aiello, P., Yang, L. T., Ménard, S., Sap, J.> ;Oncogene. 2000 Oct 12
• Detection of lymph node metastases by lymphoscintigraphy with a tumour-seeking tracer in breast cancer patients.
  Maffioli, L. S., Seregni, E., Chiesa, C., Nerini-Molteni, S., Gerali, A., Bombardieri, E., Greco, M., Agresti, R.> ;Eur J Nucl Med. 2000 Jun
• Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis.
  Greco, M., Agresti, R., Cascinelli, N., Casalini, P., Giovanazzi, R., Maucione, A., Tomasic, G., Ferraris, C., Ammatuna, M., Pilotti, S., Menard, S.> ;Ann Surg. 2000 Jul
• Join now to see all